design space – Pharma GMP

Linking QbD, Control Strategy and Routine GMP Operations

digi — Wed, 26 Nov 2025 03:30:04 +0000

Linking QbD, Control Strategy and Routine GMP Operations Integrating QbD with Process Control Strategy in Pharmaceutical Manufacturing: A Step-by-Step Guide In contemporary pharmaceutical manufacturing, the paradigm shift from traditional quality control to a proactive Quality by Design (QbD) approach has redefined how manufacturers develop and maintain robust process control strategies. Linking QbD principles, especially the...

Process Parameter Control Limits: Linking Development, Validation and Routine GMP

digi — Wed, 26 Nov 2025 01:51:04 +0000

Process Parameter Control Limits: Linking Development, Validation and Routine GMP Establishing Process Parameters Control Limits in Pharma: A Step-by-Step Guide In pharmaceutical manufacturing, control of process parameters is fundamental to ensuring product quality, safety, and compliance with regulatory expectations. Establishing scientifically sound and regulatory-compliant process parameters control limits in pharma requires a structured approach that...

Biotech GMP: Integration of Quality by Design Into Biologics Manufacturing

digi — Fri, 14 Nov 2025 20:01:47 +0000

Biotech GMP: Integration of Quality by Design Into Biologics Manufacturing Integrating Quality by Design into Biotech GMP for Biologics Manufacturing The pharmaceutical industry increasingly embraces innovative frameworks to enhance product quality and manufacturing efficiency. Among these, Quality by Design (QbD) has become a foundational approach, particularly critical in fields demanding stringent controls such as biologics....